share

Farnesylleucyl-Alanyl-Arginyl-Tyrosyl-Lysyl-Cysteine CAS NO 130447-82-4


Unit Price:

CAS No.:130447-82-4

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Farnesylleucyl-Alanyl-Arginyl-Tyrosyl-Lysyl-Cysteine is a synthetic peptide sequence of significant interest in biochemical research and pharmaceutical development. This compound matters due to its role as a potential precursor or intermediate in the study of protein prenylation, a critical post-translational modification involved in cell signaling and regulation. It is primarily needed by research institutions and biotechnology companies focused on oncology, metabolic disorders, and the development of novel therapeutic agents targeting specific enzymatic pathways.

Application

  • Biochemical Research: Used as a critical substrate or inhibitor in enzymatic assays to study farnesyltransferase and related prenylation enzymes.
  • Pharmaceutical R&D: Serves as a key intermediate in the synthesis and development of novel drug candidates targeting Ras oncoproteins and other prenylated proteins.
  • Proteomics & Signal Transduction Studies: Employed to investigate the mechanisms of cell membrane localization and the function of lipid-modified peptides in cellular communication.
  • Reference Standard: Utilized as a high-purity analytical standard for method development and quality control in peptide synthesis and characterization.
  • Academic Research: Applied in university laboratories for fundamental studies on protein chemistry, post-translational modifications, and their implications in disease.

Basic Information

Product Name Farnesylleucyl-Alanyl-Arginyl-Tyrosyl-Lysyl-Cysteine
CAS No. 130447-82-4
Molecular Formula C52H86N12O10S
Molecular Weight 1047.4 g/mol
Synonyms Farnesyl-LARKYC; Farnesyl-Leu-Ala-Arg-Tyr-Lys-Cys; Prenylated LARKYC peptide; N-[(2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trien-1-yl]-L-leucyl-L-alanyl-L-arginyl-L-tyrosyl-L-lysyl-L-cysteine; L-Leucine, N-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-, L-alanyl-L-arginyl-L-tyrosyl-L-lysyl-L-cysteine; Farnesyl peptide inhibitor; FTase substrate analog
EINECS Contact for details

Quality Control

Our Farnesylleucyl-Alanyl-Arginyl-Tyrosyl-Lysyl-Cysteine is manufactured under strict quality systems. Each batch undergoes rigorous analytical testing, including HPLC for purity, mass spectrometry for identity confirmation, and tests for residual solvents and moisture content. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all specification results to ensure compliance with your research and development requirements.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below in a dry environment. This product is hygroscopic (moisture-sensitive). Allow the vial to equilibrate to room temperature in a desiccator before opening to minimize moisture uptake.

Specification

Item Specification
Appearance White to off-white powder
Identification (HPLC/MS) Conforms
Purity (HPLC) ≥ 95.0%
Single Impurity (HPLC) ≤ 1.0%
Water Content (KF) ≤ 5.0%
Peptide Content ≥ 80.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.